Joanne Quan serves as Executive at Eiger BioPharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Joanne Quan has executed 5 insider transactions totaling $210.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 22, 2026 involved selling 1,822 shares valued at $170.0K.
Joanne Quan currently holds 12,817 shares of Eiger BioPharmaceuticals, Inc. (EIGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joanne Quan has been a net seller of EIGR stock. They have purchased $0 and sold $210.0K worth of shares.
Joanne Quan's most recent insider trade was on Jan 22, 2026, when they sold 1,822 shares at $93.33 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 21, 2026 | MIRM | $0 | Option Exercise | 3,334 | $N/A | Discretionary |
| Apr 2, 2018 | EIGR | $40.0K | Sale | 4,000 | $10.00 | Discretionary |
| Apr 2, 2018 | EIGR | $8.2K | Option Exercise | 4,000 | $2.06 | Discretionary |